A reasonable chance it could cause serious harm or death.
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
| Brand name | NP THYROID 15 |
| Generic name | LEVOTHYROXINE, LIOTHYRONINE |
| Active ingredient(s) | LEVOTHYROXINE, LIOTHYRONINE |
| Distributed by / for | Acella Pharmaceuticals, LLC Alpharetta, GA 30005 |
| NDC | 42192-327-01 |
| Full product label | NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-327-01 |
| Recalling firm | Acella Pharmaceuticals, LLC |
| Distribution | Nationwide within the United States |
| Quantity | 19,296 bottles |
| Recall initiated | 2020-09-17 |
| Report date | 2020-10-28 |
| Recall completed | 2022-12-08 |
| Recall number | D-0035-2021 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Alpharetta GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗